[Significance of COX-2].
Tatsuguchi
Atsushi
A
Third Department of Internal Medicine, Nippon Medical School.
Sakamoto
Choitsu
C
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000494:pharmacology; D051546:Cyclooxygenase 2; D005753:Gastric Mucosa / Q000201:enzymology; D016481:Helicobacter Infections / Q000201:enzymology; D016480:Helicobacter pylori; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000502:physiology*; D008565:Membrane Proteins; D009389:Neovascularization, Pathologic / Q000201:enzymology; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology*; D013276:Stomach Ulcer / Q000201:enzymology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases